Las Vegas, NV -- (SBWIRE) -- 10/11/2013 -- Value Stock Pick is a leading Investment Newsletter. Our Research Team conducts research on different stocks, doing their due diligence to provide a detailed report, including both technical and fundamental analysis, on NYSE, NASDAQ, AMEX, OTCBB and Pink Sheet Stocks. Let’s have a brief look at: Krispy Kreme Doughnuts (NYSE:KKD), OmniVision Technologies, Inc. (NASDAQ:OVTI), Trulia Inc (NYSE:TRLA), Impax Laboratories Inc (NASDAQ:IPXL).
Krispy Kreme Doughnuts (NYSE:KKD) managed to keep its gain at 0.57% on traded volume of 1.11 million shares. The stock settled at $23.08 after floating in a range of $22.96 to $23.47. After recent close, it has reached market capitalization of $1.52 billion. Its 52-week range has been $6.77 to $23.57. Krispy Kreme Doughnuts, Inc., together with its subsidiaries, operates as a branded retailer and wholesaler of doughnuts, beverages, and treats and packaged sweets worldwide.
Will KKD Continue To Move Higher? Find Out Here
OmniVision Technologies, Inc. (NASDAQ:OVTI) traded up on a volume of 1.11 million, lower than its standard daily volume. Shares have gained 0.21% to $14.02. Over the last twelve months the stock has lost -0.85% and faced a worst price of $14.00. OmniVision Technologies, Inc. engages in designing, developing, and marketing semiconductor image-sensor devices worldwide.
Will OVTI Continue To Move Higher? Find Out Here
Trulia Inc (NYSE:TRLA) settled -0.70% lower at $42.83 on traded volume of 1.11 million shares during the last trading day, while its average trading volume remained 981.178 shares. The stock has its 12-month low at $14.69 and 52-week high price was $52.71. It traded in a range of $41.83 to $44.34 during the last trading day. Trulia, Inc. provides tools to research homes and neighborhoods for consumers through Web and mobile applications. The company, through its tools, also enables real estate professionals to market their listings.
Will TRLA Get Buyers Even After The Recent Rally? Find Out Here
Impax Laboratories Inc (NASDAQ:IPXL) saw its price gain on traded volume as 1.10 million shares changed hands when compared with its average daily volume of 403.208 shares. The stock was up 0.69% to $19.80. It has fallen over the last 12 months, dropping -25.81% and marked new low $14.41. Impax Laboratories, Inc., a specialty pharmaceutical company, engages in the development, manufacture, and marketing of bioequivalent pharmaceutical products; and development and marketing of branded products.
Will IPXL Continue To Move Higher? Find Out Here
PLEASE NOTE WELL: The employees of ValueStockPick.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site, Press releases or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Please Read Our Full Disclaimer at http://www.valuestockpick.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)